“Your legacy is planting seeds that you will never see flower.
Your legacy is knowing that you’ve done better for the next generation. Your legacy is having the rebellious hope that the actions you take today will create a better society tomorrow”
Dame Deborah James
_jfif.jpg)
New £5m commitment looking into early on set bowel cancer
Earlier this month, Cancer Grand Challenges announced the five teams being awarded £100 million to take on some of cancer’s toughest challenges. The Bowelbabe Fund has committed to giving £5 million over the next five years to one of the teams, PROSPECT, to uncover the reasons behind the global rise in bowel cancer in younger adults.
Early-onset bowel (or colorectal) cancer is a cancer type that’s on the rise – each new generation faces a higher risk of developing early-onset bowel cancer. But it’s not well understood, and we don’t know for sure what’s causing it. The work that team PROSPECT is doing aims to improve our understanding.
Cancer Grand Challenges - Team OPTIMASITCC
In April 2023 we announced a £1m investment to the OPTIMISTICC Cancer Grand Challenges team who are analysing the microbiome – the trillions of bacteria, viruses and fungi residing in our bodies to find out how these microbes can drive cancer & influence a person’s response to treatment.
Royal Marsden
Cancer Charity - IR Machine
In April 2023 we announced a £1m investment IR uses imaging techniques to treat cancer in a minimally invasive way. Often used as an alternative to surgery, imaging methods such as real-time x-rays, ultrasound, CT or MRI scanning, are used to guide treatment directly to the cancer site.
_JPG.jpg)
Cancer Research UK
Test, Edvience and Transiton
We're supporting Cancer Research UK’s pioneering ‘Test Evidence Transition’ (TET) programme, which aims to improve bowel cancer diagnosis for everyone across the UK and ultimately, save more lives.
The Fund will be providing £1m of the £1.9m of the two-year programme.